<DOC>
	<DOCNO>NCT00723866</DOCNO>
	<brief_summary>Botulinum toxin type A ( BtxA ) injection modify constraint-induced movement therapy ( mCIMT ) promising approach enhance recovery stroke . However , combine application two modality rarely study . The aim investigate whether combined BtxA mCIMT would produce great improvement spasticity upper extremity function BtxA plus conventional rehabilitation chronic stroke patient upper extremity spasticity .</brief_summary>
	<brief_title>Botulinum Toxin Type A Modified Constraint-Induced Movement Therapy Poststroke Upper Extremity Spasticity</brief_title>
	<detailed_description>Botulinum toxin type A ( BtxA ) injection modify constraint-induced movement therapy ( mCIMT ) promising approach enhance recovery stroke . However , combine application two modality rarely study . To date , single case report address issue . Theoretically , application mCIMT program intensive functional task practice spasticity reduction BtxA may improve affect upper extremity function patient poststroke spasticity . The aim investigate whether combined BtxA mCIMT would produce great improvement spasticity upper extremity function BtxA plus conventional rehabilitation chronic stroke patient upper extremity spasticity .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>age 18 80 year least 1 year unilateral stroke modify ashworth scale ( MAS ) score &gt; 3 elbow , wrist finger flexor ability actively extend &gt; 10 degree metacarpophalangeal interphalangeal joint 20 degree wrist affected upper limb ( minimal motor criterion ) . presence fix joint contracture serious balance problem preexist neurological deficit , neuromuscular disease uncontrolled medical condition significant cognitive deficit ( MiniMental Status Examination score &lt; 24 ) excessive pain affect upper limb previous treatment Botulinum toxin A , neurolytic agent surgery spasticity All patient currently participate experimental study receive concomitant oral antispastic medication study period</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Botulinum toxin , Spasticity , Stroke , Rehabilitation .</keyword>
</DOC>